VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Non-Current Assets came in at $16038.0 in Q2 2026, down 58.8% on a QoQ basis from $38929.0 in Q3 2018.
VitaNova Life Sciences (VNOV) Non-Current Assets (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 3 years of Non-Current Assets data on file, last reported at $16038.0 in Q2 2026.
- Quarterly Non-Current Assets changed N/A year-over-year to $16038.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $16038.0 (changed N/A YoY) and the FY2026 annual result came in at $16038.0, changed N/A from the prior year.
- Non-Current Assets eased to $16038.0 in Q2 2026, from $38929.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $16038.0 in Q2 2026 to a low of $16038.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.32 Bn | 97.16 Bn | 3.69 Bn | 25.49 Bn |
| 2 | Cencora | 61.61 Bn | 58.79 Bn | 3.61 Bn | 28.47 Bn |
| 3 | Cardinal Health | 54.03 Bn | 49.18 Bn | 2.56 Bn | 18.55 Bn |
| 4 | Henry Schein | 10.06 Bn | 9.90 Bn | 1.10 Bn | 6.78 Bn |
| 5 | Akso Health | 686.57 Mn | 686.37 Mn | - | 87,231.00 |
| 6 | Edap Tms | 156.68 Mn | 135.14 Mn | 7.34 Mn | 15.53 Mn |
| 7 | Accendra Health | 92.42 Mn | 84.77 Mn | 263.41 Mn | 1.84 Bn |
| 8 | 111 | 30.17 Mn | -28.59 Mn | 18.18 Mn | 10.55 Mn |
| 9 | Cosmos Health | 13.02 Mn | 10.57 Mn | 1.51 Mn | 24.79 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 16,038.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 16,038.00 |
| Jul 31, 2018 | 38,929.00 |
| Apr 30, 2018 | 31,061.00 |
| Jan 31, 2018 | 51,950.00 |
| Oct 31, 2017 | 64,700.00 |
| Apr 30, 2017 | 7,925.00 |